Beam Therapeutics Inc. (BEAM) Social Stream



Beam Therapeutics Inc. (BEAM): $42.12

-2.57 (-5.75%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add BEAM to Watchlist
Sign Up

Industry: Biotech


Ranked

of 373

in industry

BEAM THERAPEUTICS INC (BEAM) Price Targets From Analysts

Use the tables below to see what analysts covering BEAM THERAPEUTICS INC think about its future price and what recommendations they have for investors and traders.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-09 10 $150 $85 $122.333 $44.37 175.71%
2021-12-22 10 $150 $85 $121.555 $44.37 173.96%
2022-01-05 11 $150 $85 $122.4 $44.37 175.86%
2022-01-10 11 $159 $85 $124.5 $44.37 180.59%
2022-02-01 10 $159 $85 $124.5 $44.37 180.59%
2022-02-28 10 $159 $85 $126.25 $44.37 184.54%
2022-03-01 9 $154 $85 $124.625 $44.37 180.88%
2022-05-09 8 $154 $110 $130.285 $44.37 193.63%
2022-05-10 8 $154 $75 $114.142 $44.37 157.25%
2022-05-11 8 $130 $75 $110 $44.37 147.92%
2022-06-08 8 $130 $75 $103.142 $44.37 132.46%
2022-06-17 9 $130 $41 $95.375 $44.37 114.95%
2022-07-18 9 $130 $61 $97.875 $44.37 120.59%
2022-08-10 10 $130 $61 $97.875 $44.37 120.59%
2022-09-17 10 $130 $60 $90.125 $44.37 103.12%
2022-11-07 10 $130 $60 $89.222 $44.37 101.09%
2022-11-08 10 $130 $60 $84.666 $44.37 90.82%

The Trend in the Analyst Price Target


BEAM's average price target has moved up $52.92 over the prior 33 months.

BEAM reports an average of 99.04% for its upside potential over the past 46 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2022-01-10 10 159 85 124.500 68.46 81.86%
2022-05-09 8 154 110 130.285 33.29 291.36%
2022-06-08 8 130 75 103.142 40.18 156.7%
2022-06-08 9 130 75 103.142 40.18 156.7%
2022-07-18 9 130 61 97.875 58.01 68.72%

BEAM Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.6 7 0 3 0 0 10

The Trend in the Broker Recommendations


Over the past 35 weeks, BEAM's average broker recommendation rating worsened by 0.16.

The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.

  • BEAM has a greater upside potential (average analyst target price relative to current price) than 1949.69% of all US stocks.
  • In the context of stocks in the mid market cap category, BEAM THERAPEUTICS INC's average analyst price target is greater than 2206.71% of them.
  • In terms of how BEAM THERAPEUTICS INC fares relative to Pharmaceutical Products stocks, note that its number of analysts covering the stock is greater than 1883.58% of that group.
  • To contextualize these metrics, consider that out of stocks in the mid market cap category, BEAM THERAPEUTICS INC's variance in analysts' estimates is lower than -1552.56% of them.

In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to BEAM THERAPEUTICS INC are SRNE, PLX, and EDIT.

Make investment decisions regarding BEAM using the data that counts. Try POWR Ratings for free.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.6059 seconds.